Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1068-1074, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brovkovych, V.
Right arrow Articles by Malinski, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brovkovych, V.
Right arrow Articles by Malinski, T.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2001;47:1068-1074.)
© 2001 American Association for Clinical Chemistry, Inc.

Articles

Nitric Oxide Measurements during Endotoxemia

Viktor Brovkovych1, Lawrence W. Dobrucki1, Svitlana Brovkovych1, Iwona Dobrucki1, Leszek Kalinowski2, Frederick Kiechle2 and Tadeusz Malinski1a

1 Department of Chemistry and Biochemistry, Ohio University, Athens, OH 45701.

2 Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, MI 48073.

aAddress correspondence to this author at: Department of Chemistry and Biochemistry, Ohio University, Clippinger Laboratories, Athens, OH 45701. Fax 740-593-9641; e-mail malinski{at}ohio.edu.

Background: Excessive continuous NO release from inducible NO synthase over prolonged periods under pathological conditions, such as endotoxemia, contributes significantly to circulatory failure, hypotension, and septic shock. This NO production during endotoxemia is accompanied by superoxide release, which contributes to the fast decay of NO. Therefore, the amount of NO that diffuses to target sites may be much lower than the total amount released under pathological conditions.

Methods: We performed in vivo and ex vivo measurements of NO (electrochemical) and ex vivo in situ measurements of superoxide, peroxynitrite (chemiluminescence), and nitrite and nitrate (ultraviolet-visible spectroscopy). We determined the effect of lipopolysaccharide administration (20 mg/kg) on diffusible NO, total NO (diffusible plus consumed in chemical reactions), and superoxide and peroxynitrite release in the pulmonary arteries of rats.

Results: An increase in diffusible NO generated by constitutive NO synthase was observed immediately after administration of lipopolysaccharide, reaching a plateau (145 ± 18 nmol/L) after 540 ± 25 s. The plateau was followed by a decrease in NO concentration and its subsequent gradual increase after 45 min because of NO production by inducible NO synthase. The concentration of superoxide increased from 16 ± 2 nmol/L to 30 ± 3 nmol/L after 1 h and reached a plateau of 41 ± 4 nmol/L after 6 h. In contrast to the periodic changes in the concentration of diffusible NO, the total concentration of NO measured as a sum of nitrite and nitrate increased steadily during the entire period of endotoxemia, from 2.8 ± 0.2 µmol/L to 10 ± 1.8 µmol/L.

Conclusions: The direct measurement of NO concentrations in the rat pulmonary artery demonstrates dynamic changes throughout endotoxemia, which are related to the production of superoxide and the subsequent increase in peroxynitrite. Monitoring endotoxemia with total nitrate plus nitrite is not sensitive to these fluctuations in NO concentration.




The following articles in journals at HighWire Press have cited this article:


Home page
 Annals of Clinical & Laboratory ScienceHome page
G. Natarajan, M. Glibetic, V. Raykova, J. P Ofenstein, R. L Thomas, and J. V Aranda
Nitric Oxide and Prostaglandin Response to Group B Streptococcal Infection in the Lung
Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 170 - 176.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
B. Altunoluk, H. Soylemez, F. Oguz, E. Turkmen, and E. Fadillioglu
An Angiotensin-Converting Enzyme Inhibitor, Zofenopril, Prevents Renal Ischemia/Reperfusion Injury in Rats
Ann. Clin. Lab. Sci., January 1, 2006; 36(3): 326 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
K. Cagli, C. Bagci, M. Gulec, B. Cengiz, O. Akyol, I. Sari, S. Cavdar, S. Pence, and H. Dinckan
In Vivo Effects of Caffeic Acid Phenethyl Ester on Myocardial Ischemia-Reperfusion Injury and Apoptotic Changes in Rats
Ann. Clin. Lab. Sci., October 1, 2005; 35(4): 440 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. M. Bateman, C. G. Ellis, and D. J. Freeman
Optimization of Nitric Oxide Chemiluminescence Operating Conditions for Measurement of Plasma Nitrite and Nitrate
Clin. Chem., March 1, 2002; 48(3): 570 - 573.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.